Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

Aleena Malik1 Temerty Faculty of Medicine,University of Toronto,Toronto,ON,CanadaView further author information

Meghan P Jairam2 Brigham & Women’s Hospital,Harvard Medical School,Boston,MA,USAView further author information

Ronald Chow1 Temerty Faculty of Medicine,University of Toronto,Toronto,ON,Canada;3 New York Proton Center,Memorial Sloan Kettering Cancer Center,New York,NY,USA

https://orcid.org/0000-0001-6195-8624 View further author information

Seyed A Mirshahvalad1 Temerty Faculty of Medicine,University of Toronto,Toronto,ON,CanadaView further author information

Patrick Veit-Haibach1 Temerty Faculty of Medicine,University of Toronto,Toronto,ON,CanadaView further author information

Charles B Simone II3 New York Proton Center,Memorial Sloan Kettering Cancer Center,New York,NY,USACorrespondence[email protected]

https://orcid.org/0000-0002-0867-3694 View further author information

References

Chow R , SimoneCB2nd, JairamMP, SwaminathA, BoldtG, LockM. Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses. Acta Oncol.61(4), 495 (2022).
PubMed Web of Science ®Google Scholar
Chow R , SimoneCB2nd, JairamMP, SwaminathA, BoldtG, LockM. Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer – a systematic review and network meta-analysis of survival data. Acta Oncol.61(4), 484–494 (2022).
PubMed Web of Science ®Google Scholar
Zhang H , ChangN, HanTet al. Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncol.17(30), 4027–4040 (2021).
PubMed Web of Science ®Google Scholar
Malik A , JairamMP, ChowR, MirshahvaladSA, Veit-HaibachP, SimoneCB2nd. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression. Future Oncol.17(30), 4027–4040 (2022).
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date